Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Direxion Daily S&P Biotech Bull 3X Shares
(ARCA:LABU)
Intraday
$82.87
-6.53
[-7.30%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$82.87
-6.53
[-7.30%]
Last update: 3:44PM
Get Real Time Here
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for Direxion Daily S&P Biotech Bull 3X Shares (ARCA:LABU)
Direxion Daily S&P Biotech Bull 3X Shares (ARCA: LABU)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 24, 2023
These ETFs Let You Maximize Your Exposure To The Biotech Industry's Performance – Whether Positive Or Inverse
Johnny Rice
-
Mar 24, 2023, 8:19AM
Tuesday, July 06, 2021
These Were The Stocks David Green Discussed On His Show This Morning
Spencer Israel
-
Jul 6, 2021, 2:47PM
Tuesday, June 08, 2021
A Biotech ETF For Aggressive, Risk-Tolerant Investors
Mark Putrino
-
Jun 8, 2021, 1:05PM
Wednesday, May 05, 2021
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
Tyler Bundy
-
May 5, 2021, 4:50PM
Thursday, October 15, 2020
Heading Into The Election, Traders Are Still Betting On Tech
Direxion
-
Oct 15, 2020, 3:09PM
Wednesday, August 12, 2020
Heating Up: Three Leveraged ETFs For Summer Earnings
Chris Dier-Scalise
-
Aug 12, 2020, 7:32AM
Tuesday, August 04, 2020
LABU Snaps Back After Rough End To July
ETF Professor
-
Aug 4, 2020, 9:12AM
Monday, June 22, 2020
With Biotech Scorching, Traders Show LABU Love
ETF Professor
-
Jun 22, 2020, 9:22AM
Tuesday, May 19, 2020
In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
Direxion
-
May 19, 2020, 9:38AM
Monday, February 10, 2020
3 Leveraged Healthcare ETFs Soaring This Month
ETF Professor
-
Feb 10, 2020, 9:39AM
Wednesday, September 04, 2019
These Are The Leveraged ETFs At Play When Trade War Worries Strike
Direxion
-
Sep 4, 2019, 9:37AM
Wednesday, June 19, 2019
A Beloved Biotech ETF Could Lure Traders Again
ETF Professor
-
Jun 19, 2019, 9:27AM
Friday, June 07, 2019
It's Time To Consider Leveraged Healthcare ETFs
ETF Professor
-
Jun 7, 2019, 9:29AM
Tuesday, April 09, 2019
Big Moves In Leveraged Biotech ETFs
ETF Professor
-
Apr 9, 2019, 9:25AM
Monday, March 25, 2019
These Are Some Of The Best-Performing Leveraged ETFs Of The Year
Chris Dier-Scalise
-
Mar 25, 2019, 1:37PM
Friday, February 01, 2019
Pharma Catches Another Case Of M&A Fever
Chris Dier-Scalise
-
Feb 1, 2019, 10:15AM
Monday, January 14, 2019
This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders
ETF Professor
-
Jan 14, 2019, 10:05AM
Wednesday, July 18, 2018
Exploring The Leveraged ETF Trade Heading Into Earnings Season
Benzinga
-
Jul 18, 2018, 12:27PM
Monday, June 04, 2018
The 2018 ASCO Meeting Continues Today, Day 4 of 5
Benzinga
-
Jun 4, 2018, 6:52AM
Friday, May 11, 2018
'From JEF health-care strategiest Jared Holz, on Trump drug speech: "TRUMP SPEECH BENIGN. NON-EVENT. COMMENTS OVERLY VAGUE. SHORTS ARE COVERING. MASSIVE WASTE OF TIME." - CNBC's Meg Tirell Tweets
Benzinga
-
May 11, 2018, 2:59PM
Pres. Trump Begins Drug Pricing Speech, Watch Shares of CVS, RAD, WBA, ESRX, IBB, Among Others
Benzinga
-
May 11, 2018, 2:11PM
Monday, May 07, 2018
The Week Ahead: Nvidia And Dropbox Earnings, April Retail Sales, Trump Drug Pricing Speech Expected
Benzinga
-
May 7, 2018, 8:01AM
Thursday, April 19, 2018
As The Market Scrambles Over Tech And Trade Fears, ETF Fund Flow Signals Interesting Rotation
Benzinga
-
Apr 19, 2018, 12:52PM
Tuesday, April 17, 2018
REMINDER: FDA Commissioner Gottlieb To Testify Before House Appropriations Committee Today; BZ NOTE: Watch For Headlines That May Affect Biotech/Pharmacy Stocks Related To Drug Pricing and PBMs
Benzinga
-
Apr 17, 2018, 7:11AM
Wednesday, March 28, 2018
For Now, Traders Endorse Biotech Rally
Benzinga
-
Mar 28, 2018, 11:43AM
Wednesday, December 13, 2017
ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More
Benzinga
-
Dec 13, 2017, 12:31PM
Tuesday, December 12, 2017
ASH Meeting Concludes Today
Benzinga
-
Dec 12, 2017, 8:52AM
Monday, December 11, 2017
American Society Of Hematology Meeting Continues Today, Day 3 of 4
Benzinga
-
Dec 11, 2017, 9:03AM
Wednesday, November 29, 2017
Short Interest And Leveraged ETFs
Benzinga
-
Nov 29, 2017, 4:46PM
CUREs For The Ordinary December Trade
Benzinga
-
Nov 29, 2017, 2:06PM
Tuesday, November 14, 2017
Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate
Benzinga
-
Nov 14, 2017, 3:49PM
Thursday, November 09, 2017
FDA Will Now Prioritize Reviews For Generic Drugs That Are Likely To Approval Ready Clost To Expiry Of 180-Day Exclusivity Awarded To First-to-File Application
Benzinga
-
Nov 9, 2017, 1:17PM
Friday, October 06, 2017
Heaps Of Healthy Health Care ETFs
Benzinga
-
Oct 6, 2017, 10:02AM
Tuesday, September 12, 2017
European Society For Medical Oncology (ESMO) 2017 Congress Concludes Today
Benzinga
-
Sep 12, 2017, 8:40AM
Monday, September 11, 2017
European Society For Medical Oncology (ESMO) 2017 Congress Continues Today, Day 4 of 5
Benzinga
-
Sep 11, 2017, 9:10AM
Saturday, September 09, 2017
What Pharmaceuticals Spend On Lobbying To Influence Trump
Benzinga
-
Sep 9, 2017, 4:28PM
Friday, September 01, 2017
Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts
Benzinga
-
Sep 1, 2017, 2:03PM
Thursday, August 31, 2017
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Benzinga
-
Aug 31, 2017, 4:37PM
Wednesday, August 16, 2017
Small Biotechs Could Hurt From Scarcity Of Cancer Trial Participants
Benzinga
-
Aug 16, 2017, 8:36AM
Friday, June 30, 2017
Cure The Summer Doldrums With Leveraged Biotech ETFs
Benzinga
-
Jun 30, 2017, 2:40PM
Tuesday, June 20, 2017
BIO International Convention Continues Today, Day 2 of 4
Benzinga
-
Jun 20, 2017, 8:24AM
Monday, June 19, 2017
BIO International Convention Begins Today, Day 1 of 4
Benzinga
-
Jun 19, 2017, 8:27AM
Tuesday, April 25, 2017
Which Leveraged ETFs Will Be Hot This Week?
Benzinga
-
Apr 25, 2017, 3:24PM
Tuesday, January 31, 2017
President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'
Benzinga
-
Jan 31, 2017, 10:57AM
Wednesday, January 11, 2017
All The Markets Trump Moved During His Speech Today
Benzinga
-
Jan 11, 2017, 3:51PM
Trump: Drug Industry Is 'Getting Away With Murder'
Benzinga
-
Jan 11, 2017, 12:15PM
Watching Weakness In Amgen,Biogen, Gilead, Mylan, Pfizer And Other Biotechs After Pres. Elect Trump Negative Statement On Drug Pricing
Benzinga
-
Jan 11, 2017, 11:25AM
Thursday, December 22, 2016
Biotech Sector Weak Headed Into Year's End
Benzinga
-
Dec 22, 2016, 1:12PM
Tuesday, September 27, 2016
Loving LABU: A Leveraged Biotech ETF On A Torrid Pace
Benzinga
-
Sep 27, 2016, 3:21PM
Thursday, August 25, 2016
Biotechs Are Down 17% Since Clinton First Put Industry On Blast Last September
Benzinga
-
Aug 25, 2016, 1:47PM
Show more